Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-06 Option Award | 2024-08-08 09:08 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-10-02 Option Award | 2023-10-03 4:19 pm | N/A 2033-10-02 | Eledon Pharmaceuticals Inc. | ELDN | Robinson James A. Jr. Director | 150,437 | $1.55 | 150,437 (Direct) | View |
2023-09-07 Option Award | 2023-09-08 3:41 pm | N/A 2033-09-07 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 10,000 | $0 | 10,000 (Direct) | View |
2023-07-25 Option Award(A) | 2023-07-28 6:05 pm | N/A 2033-07-25 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 20,000 | $0 | 20,000 (Direct) | View |
2023-07-25 Option Award | 2023-07-27 4:30 pm | N/A 2033-07-25 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-11-30 Disposition | 2022-12-01 09:23 am | N/A 2031-11-30 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Robinson James A. Jr. Director | 25,000 | $0 | 0 (Direct) | View |
2021-11-30 Option Award | 2021-12-02 7:53 pm | N/A 2031-11-30 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Robinson James A. Jr. Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-03-29 Disposition | 2021-03-31 12:30 pm | N/A 2029-03-01 | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. | 929,117 | $0 | 0 (Direct) | View |
2021-03-19 Disposition | 2021-03-19 5:36 pm | N/A N/A | Neos Therapeutics Inc. | NEOS | Robinson James A. Jr. Director | 82,860 | $0 | 0 (Direct) | View |
2021-01-10 Tax Withholding | 2021-01-12 7:02 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO; CEO/Urovant Sciences, Inc | 4,095 | $16.11 | 8,385 (Direct) | View |
2020-06-10 Option Award | 2020-06-11 8:23 pm | N/A N/A | Neos Therapeutics Inc. | NEOS | Robinson James A. Jr. Director | 23,453 | $0 | 23,453 (Direct) | View |
2020-03-23 Option Award | 2020-03-25 5:00 pm | N/A 2030-03-22 | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. | 845,732 | $0 | 845,732 (Direct) | View |
2020-01-10 Option Award | 2020-01-14 4:09 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. Director | 12,480 | $0 | 12,480 (Direct) | View |